These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19230167)

  • 1. Clinical and urodynamic efficacy of oxybutynin and verapamil in the treatment of nocturnal enuresis after formation of orthotopic ileal neobladders. A prospective, randomized, crossover study.
    El-Bahnasawy MS; Shaaban H; Gomha MA; Nabeeh A
    Scand J Urol Nephrol; 2008; 42(4):344-51. PubMed ID: 19230167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergics do not improve cure rate of alarm treatment of monosymptomatic nocturnal enuresis.
    Yucel S; Kol A; Guntekin E; Baykara M
    Urology; 2011 Mar; 77(3):721-4. PubMed ID: 21215431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of oxybutynin, pseudoephedrine and indomethacin in the treatment of primary nocturnal enuresis.
    Varan B; Saatçi U; Ozen S; Bakkaloğlu A; Beşbaş N
    Turk J Pediatr; 1996; 38(2):155-9. PubMed ID: 8701478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of verapamil on the treatment of detrusor hyperreflexia in the spinal cord injured population.
    Bodner DR; Lindan R; Leffler E; Resnick MI
    Paraplegia; 1989 Oct; 27(5):364-9. PubMed ID: 2601986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial comment. Anticholinergics do not improve cure rate of alarm treatment of monosymptomatic nocturnal enuresis.
    Wiener JS
    Urology; 2011 Mar; 77(3):724-5. PubMed ID: 21377018
    [No Abstract]   [Full Text] [Related]  

  • 6. Do holding exercises or antimuscarinics increase maximum voided volume in monosymptomatic nocturnal enuresis? A randomized controlled trial in children.
    Van Hoeck KJ; Bael A; Van Dessel E; Van Renthergem D; Bernaerts K; Vandermaelen V; Lax H; Hirche H; van Gool JD
    J Urol; 2007 Nov; 178(5):2132-6. PubMed ID: 17870123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy of imipramine with oxybutynin in children with enuresis nocturna.
    Tahmaz L; Kibar Y; Yildirim I; Ceylan S; Dayanç M
    Urol Int; 2000; 65(3):135-9. PubMed ID: 11054030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.
    Gupta SK; Sathyan G; Lindemulder EA; Ho PL; Sheiner LB; Aarons L
    Clin Pharmacol Ther; 1999 Jun; 65(6):672-84. PubMed ID: 10391673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is extended-release oxybutynin (Ditropan XL) or tolterodine (Detrol) more effective in the treatment of an overactive bladder?
    Hartnett NM; Saver BG
    J Fam Pract; 2001 Jul; 50(7):571. PubMed ID: 11485700
    [No Abstract]   [Full Text] [Related]  

  • 10. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
    Stöhrer M; Mürtz G; Kramer G; Schnabel F; Arnold EP; Wyndaele JJ;
    Eur Urol; 2007 Jan; 51(1):235-42. PubMed ID: 16698176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of effectiveness of and tolerance to oxybutynin in the treatment of unstable bladder in women].
    Serrano Brambila EA; Quiroga Avila RG; Lorenzo Monterrubio JL; Moreno Aranda J
    Ginecol Obstet Mex; 2000 Apr; 68():174-81. PubMed ID: 10824450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
    Yucel S; Akkaya E; Guntekin E; Kukul E; Danisman A; Akman S; Baykara M
    Urology; 2005 Feb; 65(2):369-73. PubMed ID: 15708055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin.
    Gupta SK; Sathyan G
    J Clin Pharmacol; 1999 Mar; 39(3):289-96. PubMed ID: 10073329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory monosymptomatic nocturnal enuresis: a combined stepwise approach in childhood and follow-up into adolescence, with attention to the clinical value of normalizing bladder capacity.
    Vermandel A; de Wachter S; Wyndaele JJ
    BJU Int; 2005 Sep; 96(4):629-33. PubMed ID: 16104923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of urodynamic findings and response to oxybutynin in nocturnal enuresis.
    Persson-Jünemann C; Seemann O; Köhrmann KU; Jünemann KP; Alken P
    Eur Urol; 1993; 24(1):92-6. PubMed ID: 8365449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxybutynin for treatment of nocturnal enuresis in children.
    Friedman BC; Friedman B; Goldman RD
    Can Fam Physician; 2011 May; 57(5):559-61. PubMed ID: 21642736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In which patients is the oxybutynin-desmopressin combination therapy indicated?].
    Martín-Crespo R; Luque R
    Cir Pediatr; 2003 Oct; 16(4):181-5. PubMed ID: 14677356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergic medication for the unstable bladder: prospective trials of imipramine/propantheline versus penthienate and oxybutynin versus penthienate.
    Clarke B
    Int Urogynecol J Pelvic Floor Dysfunct; 1996; 7(4):191-5. PubMed ID: 10895803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy with calcium antagonists in acute myocardial infarction. Hemodynamic evaluation using the hand-grip test].
    Ravazzi PA; Ivaldi M; Priolo C; Fornari P; Carosio G; Provera PF; Guarraggi F
    Minerva Cardioangiol; 1986; 34(7-8):511-6. PubMed ID: 3774166
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder.
    Chertin B; Koulikov D; Abu-Arafeh W; Mor Y; Shenfeld OZ; Farkas A
    J Urol; 2007 Oct; 178(4 Pt 2):1744-7. PubMed ID: 17707010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.